Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Arbuckle Stuart A
Relationship:   Director
City:   Cambridge,
State:   MA
   
Insider Summary:
  
   
Companies Owned :   3    
Direct Shares   62,795    

Indirect Shares

  140      
Direct Value   $23,606,546    

Indirect Value

  $66,493      
Total Shares   62,935      
Total Value   $23,673,039      


Vertex Pharmaceuticals Inc
 $23,600,740 Dare Bioscience Inc
 $5,805 Vertex Pharmaceuticals Inc
 $23,600,740 Dare Bioscience Inc
 $5,805
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    0   
    0    

     Stock price went up :

    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Vertex Pharmaceuticals Inc VRTX EVP, COO 2024-05-15 49,691 2024-05-15 140    Premium*  
            Dare Bioscience Inc DARE Director 2017-01-03 13,104 2016-10-03 0    Premium*  
            Immunogen Inc IMGN Director 2024-02-12 0 2023-06-30 0    Premium*  
* Premium Members only  

Records found :    192         Free Registration Required For Full Results.    Limit: 25

Download
  Page 8 of 8
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
VRTX Vertex Pharmaceuticals In... EVPChief Commercial Officer   •       –      –    2019-06-19 4 OE $131.89 $280,266 D/D 2,125 35,365 0 -
VRTX Vertex Pharmaceuticals In... EVPChief Commercial Officer   •       –      –    2019-08-02 4 OE $91.05 $196,213 D/D 2,155 34,395 0 -
VRTX Vertex Pharmaceuticals In... EVPChief Commercial Officer   •       –      –    2019-08-05 4 OE $86.52 $134,366 D/D 1,553 33,793 0 -
VRTX Vertex Pharmaceuticals In... EVPChief Commercial Officer   •       –      –    2019-08-08 4 OE $131.89 $280,266 D/D 2,125 35,365 0 -
VRTX Vertex Pharmaceuticals In... EVPChief Commercial Officer   •       –      –    2019-11-04 4 OE $86.52 $330,578 D/D 3,708 34,793 0 -
VRTX Vertex Pharmaceuticals In... EVP, Chief Commercial Officer   •       –      –    2020-01-31 4 OE $187.53 $879,891 D/D 4,692 37,932 0 -
VRTX Vertex Pharmaceuticals In... EVP, Chief Commercial Officer   •       –      –    2020-02-03 4 OE $86.52 $330,756 D/D 3,710 36,950 0 -
VRTX Vertex Pharmaceuticals In... EVP, Chief Commercial Officer   •       –      –    2020-02-06 4 OE $155.57 $483,559 D/D 2,787 70,350 0 -
VRTX Vertex Pharmaceuticals In... EVP, Chief Commercial Officer   •       –      –    2020-05-04 4 OE $86.52 $134,366 D/D 1,553 36,732 0 -
VRTX Vertex Pharmaceuticals In... EVP, Chief Commercial Officer   •       –      –    2020-07-07 4 OE $155.57 $483,403 D/D 2,786 37,965 0 -
VRTX Vertex Pharmaceuticals In... EVP, Chief Commercial Officer   •       –      –    2020-08-03 4 OE $86.52 $134,366 D/D 1,553 36,732 0 -
VRTX Vertex Pharmaceuticals In... EVP, Chief Commercial Officer   •       –      –    2020-11-03 4 OE $86.52 $134,366 D/D 1,553 36,732 0 -
VRTX Vertex Pharmaceuticals In... EVP, Chief Commercial Officer   •       –      –    2021-02-03 4 OE $86.52 $134,452 D/D 1,554 71,511 0 -
VRTX Vertex Pharmaceuticals In... EVP, COO   •       –      –    2022-08-09 4 OE $155.57 $299,628 D/D 1,926 66,686 0 -
VRTX Vertex Pharmaceuticals In... EVP, COO   •       –      –    2022-08-10 4 OE $155.57 $9,956 D/D 64 61,060 0 -
VRTX Vertex Pharmaceuticals In... EVP, COO   •       –      –    2022-08-15 4 OE $155.57 $1,022,250 D/D 6,571 67,451 0 -
VRTX Vertex Pharmaceuticals In... EVP, COO   •       –      –    2023-12-13 4 OE $187.53 $1,613,321 D/D 8,603 65,159 0 -

  192  Records found
  1   2   3   4   5   6   7   8     
  Page 8 of 8  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed